Elevation of creatine phosphokinase in moderate-to-severe atopic dermatitis is associated with the use of JAK inhibitors but not dupilumab: A systematic review and meta-analysis

被引：0
|
作者：
Manzar, Daud
Suntres, Emmanuel [1 ]
Nair, Nikhil
Patel, Yash [1 ]
Abu-Hilal, Mohannad [2 ,3 ]
机构：
[1] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[2] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[3] McMaster Univ, Div Dermatol, 100 Main St West, Hamilton, ON L8P 1H6, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 91卷 / 01期
关键词：
abrocitinib; atopic dermatitis; creatine phosphokinase; dupilumab; JAK-inhibitor; upadacitinib;
D O I：
10.1016/j.jaad.2024.03.027
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：168 / 169
页数：2
相关论文
共 50 条
  • [1] Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
    Wang, Fa-Ping
    Tang, Xiao-Ju
    Wei, Chuan-Qi
    Xu, Lin-Rui
    Mao, Hui
    Luo, Feng-Ming
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 90 (02) : 190 - 198
  • [2] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
    James E. Frampton
    Hannah A. Blair
    American Journal of Clinical Dermatology, 2018, 19 : 617 - 624
  • [3] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
    Frampton, James E.
    Blair, Hannah A.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (04) : 617 - 624
  • [4] Cardiovascular and metabolic outcomes associated with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
    Untaaveesup, Suvijak
    Amnartpanich, Thipsukon
    Jirattikanwong, Noraworn
    Boonsom, Anchaya
    Treemethawee, Treedanuch
    Srichana, Pornteera
    Yimkijboriharn, Chettha
    Phinyo, Phichayut
    Laisuan, Wannada
    Thongngarm, Torpong
    WORLD ALLERGY ORGANIZATION JOURNAL, 2025, 18 (03):
  • [5] Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis
    Ou, Zuzhen
    Chen, Chao
    Chen, Aijun
    Yang, Yao
    Zhou, Weikang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 54 : 303 - 310
  • [6] Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
    Gao, Qin
    Zhao, Yanxia
    Zhang, Junling
    HELIYON, 2023, 9 (06)
  • [7] The use of dupilumab in children and adolescents with severe atopic dermatitis: a systematic review and meta-analysis
    da Cruz, Maria Fernanda Mollaco Navarro
    Tristao, Luca Schiliro
    dos Santos, Clara Lucato
    Mattos e Dinato, Sandra Lopes
    Bernardo, Wanderley Marques
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2025, 71 (01):
  • [8] PREVALENCE OF CREATINE PHOSPHOKINASE ELEVATION IN PATIENTS RECEIVING IMMUNOMODULATORY THERAPIES FOR ATOPIC DERMATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Suntres, Emmanuel
    Manzar, Daud
    Nair, Nikhil
    Patel, Yash
    Abu-Hilal, Mohannad
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 34 - 35
  • [9] Dupilumab in Combination With JAK Inhibitor for Refractory Moderate-to-Severe Atopic Dermatitis
    Song, Xiaoting
    Liu, Bo
    Peng, Chengyue
    Tan, Yen
    Zhao, Zuotao
    DERMATOLOGIC THERAPY, 2024, 2024 (01)
  • [10] Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis
    Huang, Yuanjie
    Cai, Limin
    Wu, Xuerui
    Chen, Chen
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 725 - 733
12345